BioSpace News Archive

The NYC Test & Trace Corps and DocGo, a leading provider of last-mile telehealth and integrated medical mobility services that has entered into an agreement to merge with Motion Acquisition Corp. (

Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced the appointment of two experienced professionals to support its patient advocacy initiatives and ongoing clinical operations

NeuroOne Medical Technologies Corporation (OTCQB: NMTC; NeuroOne or the Company), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces today that CEO Dave Rosa will make a live appearance on the Big Biz Show, April 5, 2021,

Alio Medical (“Alio”), a wearable technology company focused on enabling insights through clinical-grade real-time data, today announced that Eric Hargan will join its Board of Directors as an Observer effective March 2021.

MatMaCorp (Materials and Machines Corporation), a developer of comprehensive molecular diagnostic systems, today announced the launch of its new hand-held device capable of conducting polymerase chain reaction (PCR) amplification and real-time fluorescent detection, anytime, anywhere.

Today, Olive Labs announced their partnership with Concentric by Ginkgo to provide a scalable, accessible, and simple testing modality for COVID-19 - pooled testing - to serve schools operating hybrid or in-person learning

Matrix Clinical Solutions, a Matrix Medical Network® (Matrix) business, is now offering a cost-effective and accurate at-home RT-PCR testing solution for companies looking to provide convenient COVID-19 testing for employees in the comfort of their own home.

Claims address computer-implemented systems and methods for filtering noise from input cardiac signals using its PURE EP™ technology designed to elevate treatments for cardiac arrhythmias Atrial fibrillation is the most common arrhythmia type, affecting over 6 million people in the U.S. and causing more than 750,000 hospitalizations each year

Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, today announced a preliminary forecast revenue range for the first quarter 2021, ahead of its participation in the Wells Fargo MedTech R&D Spotlight Call Series to be held at 1:00 p.m. Eastern Time on March 30, 2021.

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global biotechnology company focused on developing and commercializing innovative medicines, today announced that Julia Wang has been appointed as Chief Financial Officer, effective June 30, 2021.